A detailed history of Spinnaker Investment Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Spinnaker Investment Group, LLC holds 3,731 shares of ABBV stock, worth $635,575. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,731
Previous 3,564 4.69%
Holding current value
$635,575
Previous $611,000 20.46%
% of portfolio
0.18%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $27,361 - $33,288
167 Added 4.69%
3,731 $736,000
Q2 2024

Jul 24, 2024

SELL
$154.79 - $180.76 $78,014 - $91,103
-504 Reduced 12.39%
3,564 $611,000
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $10,228 - $11,654
64 Added 1.6%
4,068 $740,000
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $9,356 - $10,537
-68 Reduced 1.67%
4,004 $620,000
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $3,339 - $3,866
25 Added 0.62%
4,072 $606,000
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $530 - $659
4 Added 0.1%
4,047 $545,000
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $34,272 - $39,469
237 Added 6.23%
4,043 $644,000
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $25,172 - $30,188
182 Added 5.02%
3,806 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $53,549 - $61,418
399 Added 12.37%
3,624 $486,000
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $4,954 - $6,298
36 Added 1.13%
3,225 $494,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $39,198 - $48,633
297 Added 10.27%
3,189 $518,000
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $310,687 - $393,109
2,892 New
2,892 $391,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Spinnaker Investment Group, LLC Portfolio

Follow Spinnaker Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spinnaker Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spinnaker Investment Group, LLC with notifications on news.